Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1610246

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1610246

Pharmaceutical Glycerine Market by Utility (Care Products, Excipient), Source (Animal, Plant) - Global Forecast 2025-2030

PUBLISHED:
PAGES: 194 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Pharmaceutical Glycerine Market was valued at USD 37.47 million in 2023, expected to reach USD 39.40 million in 2024, and is projected to grow at a CAGR of 5.94%, to USD 56.13 million by 2030.

Pharmaceutical glycerine, a versatile polyol compound, plays a pivotal role in various applications due to its non-toxic, hygroscopic, and solvent properties. It is primarily used in drug formulations, cosmetics, and personal care products as a humectant, preservative, and sweetener. Its necessity stems from its ability to enhance the stability, texture, and shelf life of products. The end-use scope spans pharmaceuticals, where it acts as a carrier for active ingredients, to consumer goods where it is employed in creams, lotions, and capsules. Market growth is influenced by increasing demand from the pharmaceutical and cosmetics sectors, alongside rising consumer awareness concerning health and wellness products. The expansion in biotechnological applications, particularly in drug delivery systems, signifies an emerging opportunity. Embracing these trends, companies can explore innovations in glycerine formulations to improve bioavailability and functionality. Growing research into bio-based glycerine, driven by sustainability trends, represents another promising avenue, with potential applications in green chemistry and eco-friendly products. However, market growth is constrained by factors such as fluctuating raw material prices and stringent regulatory requirements regarding product safety and efficacy. Supply chain disruptions pose additional challenges. Companies can mitigate these limitations by investing in diversified sourcing and complying with international standards to ensure product consistency. Regarding innovation, areas such as enhanced glycerine derivatives, novel applications in biotechnology, and bio-refinery processes present opportunities for differentiation and competitive advantage. Collaborations with research institutions could facilitate breakthroughs in these areas. The market exhibits traits of steady growth, with increasing competition and a need for continuous innovation to maintain market position. Companies are urged to bolster research and development efforts and adapt swiftly to evolving consumer preferences and regulatory landscapes to harness market potential effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 37.47 million
Estimated Year [2024] USD 39.40 million
Forecast Year [2030] USD 56.13 million
CAGR (%) 5.94%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Glycerine Market

The Pharmaceutical Glycerine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing usage as excipients in pharmaceutical preparations
    • Rising adoption of natural ingredients
    • Increasing application in the treatment of eye pressure conditions
  • Market Restraints
    • Adverse effects of pharmaceutical glycerine
  • Market Opportunities
    • Rising R&D activities to develop pharmaceutical glycerine
    • Improvements in supply chain and distribution network
  • Market Challenges
    • Availability of low cost substitutes

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Glycerine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Glycerine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Glycerine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Glycerine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Glycerine Market

A detailed market share analysis in the Pharmaceutical Glycerine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Glycerine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Glycerine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Glycerine Market

A strategic analysis of the Pharmaceutical Glycerine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Glycerine Market, highlighting leading vendors and their innovative profiles. These include Archer Daniels Midland Company, Emery Oleochemicals Group, Fisher Scientific Co. L.L.C., GJ Chemical, Godrej Group, Merck KGaA, Munzer Bioindustrie GmbH, Oleon NV, Pon Pure Chemicals Group, Procter and Gamble Company, Reagents, Renewable Energy Group Inc., Sulzer Ltd, The Chemical Company, and Viterra Magdeburg GmbH.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Glycerine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Utility, market is studied across Care Products and Excipient.
  • Based on Source, market is studied across Animal and Plant.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-742BD5183818

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing usage as excipients in pharmaceutical preparations
      • 5.1.1.2. Rising adoption of natural ingredients
      • 5.1.1.3. Increasing application in the treatment of eye pressure conditions
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects of pharmaceutical glycerine
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising R&D activities to develop pharmaceutical glycerine
      • 5.1.3.2. Improvements in supply chain and distribution network
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of low cost substitutes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Glycerine Market, by Utility

  • 6.1. Introduction
  • 6.2. Care Products
  • 6.3. Excipient

7. Pharmaceutical Glycerine Market, by Source

  • 7.1. Introduction
  • 7.2. Animal
  • 7.3. Plant

8. Americas Pharmaceutical Glycerine Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pharmaceutical Glycerine Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Glycerine Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Archer Daniels Midland Company
  • 2. Emery Oleochemicals Group
  • 3. Fisher Scientific Co. L.L.C.
  • 4. GJ Chemical
  • 5. Godrej Group
  • 6. Merck KGaA
  • 7. Munzer Bioindustrie GmbH
  • 8. Oleon NV
  • 9. Pon Pure Chemicals Group
  • 10. Procter and Gamble Company
  • 11. Reagents
  • 12. Renewable Energy Group Inc.
  • 13. Sulzer Ltd
  • 14. The Chemical Company
  • 15. Viterra Magdeburg GmbH
Product Code: MRR-742BD5183818

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL GLYCERINE MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL GLYCERINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PHARMACEUTICAL GLYCERINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PHARMACEUTICAL GLYCERINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL GLYCERINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL GLYCERINE MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY CARE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY EXCIPIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY PLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 99. PHARMACEUTICAL GLYCERINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. PHARMACEUTICAL GLYCERINE MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!